Munich, May 18, 2021 – The German Aerosol Therapy Symposium (DATS) and VisionHealth GmbH, pioneer in digital support for inhalation therapy for the treatment of chronic respiratory diseases, have held a webinar on digital innovation about the opportunities and risks of artificial intelligence in the Informed pulmonary medicine.
The central topic of the three lectures was how solutions from the field of smart medicine and artificial intelligence (AI) can support doctors and patients in diagnosing respiratory diseases and in inhalation therapy.
Dr. Sabine Häusermann, CEO and founder of VisionHealth, moderated the webinar and summarized: “It’s refreshing when there are not only AI critics, but also people who see the opportunities offered by technology. However, not all questions in this field have been answered by a long way. We should use the momentum that digital medicine has acquired through the COVID-19 pandemic, among other things, to further develop and use artificial intelligence for the benefit of all of us.”